Atovaquone
NDC 0121-0956, Atovaquone, suspension, from PAI Holdings, LLC dba PAI Pharma.
- Product NDC
- 0121-0956
- Status
- Listed
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214272
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0121-0956 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATOVAQUONE750 mg/5mL
Pharmacologic classes
Antimalarial [EPC]; Antiprotozoal [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0121-0956-08 | 00121095608 | 1 BOTTLE in 1 CARTON (0121-0956-08) / 210 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/df6086d3-6100-422a-bf23-e9610027749bNADAC price for package 00121095608
GET /v1/drugs/nadac/00121095608
Use it
Look up 0121-0956 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0121-0956 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0121-0956. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.